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EDITORIAL REVIEW
Hyperglycemia and intestinal and renal glucose transport:
Implications for diabetic renal injury
An important transport function of both the small intestine and
renal proximal tubule is the bulk transfer of glucose from lumen
to the perfusing blood. Incomplete reabsorption of filtered glu-
cose in the kidney (as in poorly controlled diabetes mellitus, or
more rarely, familial renal glycosuria, and other proximal tubu-
lopathies), or inefficient intestinal glucose transport (as in glucose!
galactose malabsorption), induces osmotic effects that have con-
sequences for fluid and electrolyte homeostasis. The mechanism
of glucose movement across the intestinal absorptive cell (entero-
cyte) displays striking similarities to that occurring in the renal
proximal tubule. In this review we discuss recent information
concerning the molecular processes underlying intestinal and
renal glucose transport, drawing parallels and making compari-
sons between them. We also consider the specific adaptations that
occur in response to diabetic hyperglycemia and the possible
humoral signals that mediate these changes. Lastly, we discuss the
potential relationship of derangements in renal tubular transport
of glucose in diabetes to the renal injury, and disturbance of
sodium handling seen in this condition.
Cellular and molecular aspects of sugar transport
Epithelial sugar transport consists of two sequential processes.
Movement from lumen to cell across the brush border membrane
(BBM) is followed by its exit from cytosol to extracellular fluid
across the basolateral membrane (BLM). The currently accepted
model of transcellular glucose movement across the epithelia of
the small intestine and proximal tubule is illustrated in Figure 1.
Movement of glucose across the BBM is an uphill process,
driven by Na concentration and electrical gradients across the
luminal (apical) cell membrane. The normally low intracellular
Na concentration is a consequence of its active extrusion by the
BLM-located Na,K-ATPase, and the BBM potential difference
arises from the ionic permeability characteristics of this mem-
brane. A Na-dependent glucose transporter (SGLT) is respon-
sible for linking glucose (or galactose) movement with the BBM
electrochemical gradient. In the small intestine, only one SGLT
isoform has been identified so far. Using the frog Xenopus oocyte
expression system, Wright and Hediger cloned this symporter and
sequenced the protein (SGLT1) from several species, including
humans [1, 2]. The expressed protein exhibits similar glucose
transport properties to those shown by intact intestine, namely a
high affinity for glucose (transport kinetic equivalent of enzyme
kinetic Km) (KT = 300 to 500 jIM), an absolute requirement for
Na (1:2 glucose:Na stoichiometry; KT for Na = 30 mM) and
competitive inhibition by phloridzin (phiorizin). There is now
more information about the relationship between the structure of
SGLT1 and its function [31. Rabbit SGLT1 consists of 662 amino
acids (molecular weight 73 to 75 kDa) and contains twelve
membrane-spanning helices. Each membrane span is composed
of 21 residues arranged in an a-helix. Kinetic studies have
identified three SGLTI transitional steps during Na-dependent
glucose transport [4]. The first is caused by the binding of two Na
ions that results in increased affinity for glucose (Km changes from
approximately 50 to 0.5—1 mM) and the attachment of one glucose
molecule. A second conformational change then presents the Na
and glucose binding sites to the cytoplasm where the low Na
concentration reduces the affinity of the protein for glucose, and
glucose is released into the cell. The final transition causes the
Na and glucose binding sites to be oriented back to the external
surface; this step is influenced by the magnitude of the membrane
potential and the net negative charge on the protein. Recent work
suggests that the activity and properties of SGLT1 are altered by
a membrane-associated regulatory protein (RS1). The capacity
for expressed SGLT1-mediated sugar transport in Xenopus
ooeytes was increased 40-fold after co-injection of RS1-cDNA [51.
Furthermore, the kinetic properties of SGLTI may change and
cause it to behave either as a high, or low, affinity transporter,
depending on the relative amounts of SGLT1 and RS1. The
existence of regulatory proteins for SGLT1 could have implica-
tions for interpreting the mechanisms of adaptation of SGLT-
mediated glucose transport in kidney and intestine, particularly in
the short-term.
Human SGLT1 consists of 664 amino acids and has 84%
sequence homology to rabbit SGLT1 [6]. Defects in its expression
are rare but the autosomal recessive disease, glucose/galactose
malabsorption (GGM), has been studied in some detail. This
disease is characterized by severe watery diarrhea that ceases
within one hour of removing digestible carbohydrates containing
glucose and galactose from the diet. Absorption of fructose is
unaffected in this condition. It is now clear that there are several
mutations that can result in GGM [2]. In one patient group the
disease has been shown to he caused by a missense mutation in
SGLT1 resulting in asparagine substitution for aspartate at posi-
tion 28. Since this aspartate residue in both wild type SGLT1 and
other Na-dependent transporters is present at the boundary
between the amino-terminus and the first transmembrane seg-
ment, it seems to be crucial for Na-dependent transporter
activity.
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One feature of intestinal glucose transport that has not been
adequately addressed is how the presence of a single BBM
transporter with a KT for Na-dependent transport in the mM
range is able to handle much higher local concentrations of
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Fig. 1. Generalized mechanism of glucose
transport across the intestinal (villous) enterocyte
and renal proximal tubule cell. In both tissues,
the uphill glucose movement at the brush
border utilizes a Na-dependent glucose
transporter (SGLT) and the process is driven
by both Na and electrical gradients. Efflux of
accumulated glucose at the basolateral
membrane occurs by facilitated sugar transport
mediated by GLUT2, and probably GLUTI and
perhaps GLUT5.
substrate effectively. Luminal glucose concentration in the upper
jejunum may exceed 50 ms 17, 8] and concentrations in the
unstirred layer, close to the site of terminal carbohydrate diges-
tion, are probably much higher. Possibilities for effective glucose
uptake under these conditions include (1) facilitated transport at
the BBM [9, 10], and (2) the recent observation that the proton
gradient across the BBM is able to drive SGLT1-mediated glucose
transport, reducing glucose affinity, but increasing transport ca-
pacity [11]. Like the RS1 regulatory protein referred to earlier,
such proton-dependence of SGLT1 could also influence whether
it behaves as a low affinity/high capacity, or a high affinity/low
capacity glucose transporter in acidic, or alkaline, environments,
respectively; this may be particularly relevant to adaptive changes
in glucose transport along the small intestine [ii].
All regions of the small intestine (duodenum, jejunum and
ileum) display Na-dependent glucose transport [12], but the
maximum capacity for transport in the jejunum is markedly higher
than in the ileum [13]. This segmental distribution might simply be
the consequence of a proximal to distal gradient of luminal
glucose concentration (and pH, see above), glucose concentra-
tions being far greater in the upper than lower small intestine [8,
14]. In this context it is worth noting that exposure of the jejunal
epithelium to raised concentrations of luminal glucose enhances
both glucose uptake [15, 16] and SGLT1 expression [16]. At the
villus level, immunohistochemical data show that expression of
SGLTI begins late in enterocyte maturation, from crypt to villus
tip, maximal levels being detected at the upper villus [12, 14].
Profiles of SGLTI density, phiorizin-dependent sugar uptake, and
BBM potential difference, during enterocyte maturation are also
very similar [14, 17, 18]. Interestingly, maximal levels of SGLTI
mRNA are reached at a much earlier stage in enterocyte matu-
ration, suggesting translational or post-translational control of
expression of the transporter during cell transit from lower to
upper villus [17]. Very little is known about the mechanisms for
intracellular targeting of SGLT1, although recent studies using
Madin-Darby canine kidney (MDCK) cells seem to indicate that
the primary amino acid sequence of SGLT1 contains the infor-
mation required for its translocation to the apical membrane [19].
Kidney
SGLT-mediated glucose absorption along the ncphron ac-
counts for around 5 to 10% of filtered sodium reabsorption,
significantly more than aldosterone-mediated sodium absorption
[201. However, in contrast to the small intestine, at least two
SGLT isoforms are found in renal tissue: SGLT1 has been
localized throughout the rat and rabbit proximal tubule, but
SGLT2, which has a lower affinity for glucose, and a 1:1 glucose:
Na stoichiometry, is also present in BBM of early proximal
tubules (Si) [21]. Evidence for this low affinity/high capacity
isoform of SGLT was originally found in rabbit kidney [22], and
more recently in human kidney [21]. It does not transport
galactose and shares 60% homology with SGLT1. SGLT2 may
also he similar to other less well characterized Na-dependent
glucose transporters, rkSTl [23] and SAATI [24].
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Tabk 1. Isoforms of the Natdependent (SGLT) and facilitative (GLUT) glucose transporters identified in cell plasma membranes, their major
tissues of expression, cell membrane location and likely function
Transporter Tissue localization Cell and membrane localization Likely function
SGLTI Small intestine and kidncy Enterocyte and proximal renal tubule cell
apical membrane
Na -dependent (2:1); mediates net glucose absorption in
small intestine and proximal tubule. KT < 0.5 mu
SGLT2 Kidney Proximal renal tubule cell apical
membrane
Na*dcpendent (1:1); mediates net glucose absorption in
small intestine and proximal tubule. KT = 1—2 mM
GLUT1 Ubiquitous. High
expression in brain,
placenta, eye and testis,
Lower expression in
small intestine and
kidney
Endothelium, erythrocytes, intracellular
endosomes and basolateral membrane
of some polarized epithelia, including
immortalized cell lines (e.g., Caco-2)
KT = 5—10 mu. Operates close to Provides basal
glucose exchange between tissue and blood, maintaining
energy supply for cell growth and proliferation. Also
transports glucose across the blood-brain barrier
GLUT2 High expression in liver,
small intestine,
pancreatic 13-cell and
kidney
Basolateral membrane of enterocytes and
proximal renal tubule cells, and
sinusoidal membrane of hepatocytes
KT = 20—40 m. Ambient blood glucose 5—10 mM,
therefore may act as a glucose sensor. High capacity
glucose transporter operating basolaterally in series with
apical SG[.T in enterocytes and proximal tubule cells
GLUT3 Brain and placenta Neurons (axon), syncytiotrophoblast and
apical membrane of polarized
epithelial cell lines (e.g. Caco-2)
K. = 1—5 mu. Nutrient transfer. Glucose-regulated
GLUT4 Skeletal and cardiac
muscle, adipose tissue
and kidney
lnulin-dcpendent translocation from
intracellular vesicles to cell surface
(plasma) membrane
Rapid glucose disposal in response to insulin. important in
whole body glucose homeostasis. May be defective in
states of insulin-resistance, including some models of
hypertension
GLUTS High expression in
intestine; less in kidney,
brain, muscle, fat, testes
and sperm
Apical and hasolateral (human)
membranes of enterocytes (jejunum).
? proximal renal tubule and ? apical
membrane
Higher affinity for fructose than glucose. Intestinal fructose
absorption
Another isoform, GLUT 7, has recently been identified; it is thought to be located in the endoplasmic reticulum (ER) and to mediate glucose
transport from the ER lumen to the cytoplasm following gluconeogenesis; ? indicates uncertain.
The axial distribution of these two SOLT isoforms makes for a
more efficient sugar uptake along the renal tubule, since luminal
glucose concentrations fall progressively and the bulk of filtered
glucose is usually absorbed by the end of the SI sub-segment.
Surprisingly, intestinal-type SGLT1 has not been detected in
human proximal tubule [21]. However, failure to identify this
protein by Western blotting may reflect either a low level of
expression in humans, or the existence of an uncharacterized high
affinity SGLT1-like isoform [221.
Na -dependent glucose transport across intestinal [25] and
renal [26, 27] BBM is reduced by experimental increases in
membrane fluidity. This indicates that the activity of SGLT
proteins is modified by the lipid composition of the brush border
and this could have implications for altered renal sugar transport
in some diseases [28].
Na
-independent glucose transport
The diet of Western populations contains up to 8% fructose
and the transporter GLUT5 in intestinal, and probably renal,
BBM [29, 30], and intestinal BLM [31], functions to transport
fructose into (and out of) the cell [32]. GLUTS is a member of the
facilitated glucose transporter family and at least five different
GLUTs have been identified. These transporters move glucose
down its concentration gradient by a Na -independent process,
and each GLUT isoform has specific characteristics and tissue
localization (Table 1). At the intestinal BBM there is evidence
that GLUT5 may also facilitate the transfer of glucose [33],
especially at the luminal concentrations present during peak
digestion. Increasing amounts of ingested fructose have been
linked to the rising incidence of hypertriglyceridemia and hyper-
insulinemia in developed countries, and this has stimulated inter-
est in the intestinal handling of this sugar [34].
Movement of glucose across the BLM occurs by facilitated
diffusion. In the small intestine GLUT2, another isoform of the
facilitated glucose transporter family with low affinity (KT = 20 to
40 mM), and high capacity, for glucose is responsible for both
glucose and fructose exit from the cell. The expression of GLUT2,
like SGLT1, increases during enterocyte maturation [35]. Glucose
transfer from proximal tubule cells to blood also utilizes GLUT2
[35, 36], but in addition the higher affinity GLUTI (the erythroid/
brain transporter, K1. = 5 to 10 mM) is expressed [36]. Moreover,
GLUT2 is normally restricted to the early, SI, portion [36],
whereas GLUTI has been detected along the entire proximal
tubule. The unequal distribution of high and low affinity SGLT
and GLUT transporters along the proximal tubule reflects their
specific functional roles in the handling of filtered glucose (Fig. 2).
Thus, the glucose concentrations similar to those in plasma found
in the early proximal tubule (Si segment) arc most effectively
handled by low affinity, high capacity transporters at both BBM
and BLM, while higher affinity and lower capacity tranporters
(SGLTI and GLUTI) are more effective in scavenging glucose
from the low levels found in the lumen of S2 and S3 segments. The
glucose transporters that have been isolated and characterized so
far arc listed in Table 1. The nature and location of those found
in gut and kidney epithelia are summarized in Table 2 and Figure
2.
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GLUT2
Fig. 2. Axial distribution of apical (brush
border—BBM) SGLT and basolateral (BLM)
GLUT transporters along the nephron. SI, S2
and S3 are sub-segments of the proximal renal
tubule; TAL is the thick ascending limb; DT, is
the distal tubule; CD is the collecting duct (see
also Table 2).
Table 2. Glucose transporter isoforms (Natdependent SGLT and
facilitative GLUT) and their distribution in small intestinal and renal
epithelial
Proximal
Transporter
Small
intestine
Glomerulus/
microvasculature
tubule
(Si, S2, S3)
Distal
nephron
SGLTI + BBM, all
regions
— + BBM, S3
SGLT2 — + BBM, Si —
GLUT 1 + BLM + + BLM, S3 + CDGLUT2 + BLM,
proximal/mid-
— + BLM, Si —
GLUT4 + ?/+ TALGLUT5 + BBM, +
BLM
(human)
— + (?BBM),
S3
—
Abbreviations are: BBM, brush border membrane; BLM, basolateral
membrane; TAL, thick ascending limb; CD, collecting duct; absent, +
present, ? uncertain.
Hyperglycemia and the expression of glucose transporters
Intestine
It has been recognized for over 50 years that animals made
diabetic using the pancreatic /3-cell cytotoxins alloxan, or strepto-
zotocin, (models of insulin-dependent type 1 diabetes mellitus;
this model of type 1 insulin-dependent diabetes does not have an
immunological basis, and may not be directly comparable to this
form of diabetes mellitus in humans) have an elevated rate of
intestinal glucose absorption. One study of human intestinal
mucosa taken from diabetics has also reported increased sugar
uptake [37]. Although other studies of human tissue have failed to
detect increased intestinal sugar transport in diabetes, ethical
considerations have prevented tissue being taken from diabetics in
whom insulin therapy has been withheld long enough for these
studies to be comparable with those done in experimental ani-
mals. The effects of experimental diabetes on intestinal sugar
transport have been reviewed in detail elsewhere [38]. Although
mueosal hypertrophy is responsible for part of the response to
diabetes, there is also an increased ability to transport glucose at
the level of individual enterocytes [391. The recent availability of
specific transporter antibodies and oligonucleotide mRNA
probes, and the use of Western and Northern blotting, as well as
immunohistochemistry, have provided important insights into the
changes in cellular regulation of glucose transport observed in
experimental diabetes mellitus.
The jejunal response to chronic diabetes is characterized by an
unchanged density of SGLT1 in membranes of individual entero-
cytes at all stages of cell maturation. However, longer villi with an
increased proportion of mature cells results in increased epithelial
expression of the protein [14, 40] and its mRNA [40, 41]. This
conclusion is supported by results obtained from analysis of
phlorizin binding to villus-attached enterocytes [42], and sugar
accumulation by enteroeytes harvested from specific villus regions
[39]. At the cellular level, hyperpolarization of the BBM stimu-
lates SGLT1-mediated glucose uptake by increasing the electro-
chemical driving force across the BBM [43], which is due to a fall
in amiloride-sensitive Na conductance [44]. This increased po-
tential difference is seen as early as one day after streptozotocin
treatment [45]. Moreover, intravenous infusion of glucose to
reproduce blood glucose concentrations found in diabetes, also
causes rapid BBM hyperpolarization, within 30 minutes [46]. One
recent and intriguing finding is that both acute and chronic
diabetes cause the targeting of cytoplasmic GLUT2 to the brush
border. Evidence for this comes from Western blotting of BBM
[47, 48] and the observation that phlorizin-insensitive (but phlor-
etin-sensitive) uptake across this membrane is elevated by diabe-
tes [9]. Concerning BLM adaptation to diabetes, increased mem-
brane-bound GLUT2 is likely to be responsible for the higher
capacity for glucose exit from the cell [44]. As with the BBM,
enhanced glucose movement across the BLM can be detected
within four hours after the intravenous infusion of glucose [49,
50]. The rapid time course of enterocyte adaptation revealed by
the response to hyperglycemia, suggests that transport changes
SGLT2 \ SGLT2 ?GLUT1/
GLUT4
?GLUT1
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occur during the time required for digestion and absorption of a
meal.
Kidney
Less detailed information is available concerning renal adapta-
tion to diabetes. Enhanced glucose absorption by the kidney in
diabetes is linked to renal hypertrophy and an increased filtered
load of glucose due to a higher GFR [201. At the level of
individual cells there is conflicting information concerning the
effect of diabetes on glucose transport. Studies using purified
membrane vesicles have reported both increased [511 and de-
creased [52, 53] SGLT-mediated glucose transport in streptozo-
tocin-treated rats, whereas glucose uptake across intact renal
tubular epithelium appears to be enhanced by diabetes [54]. This
apparent discrepancy may be due to the dose of streptozotocin
used to induce diabetes, and whether the experimental animals
are ketotic and lose weight. Proximal tubules of diabetic rats
exhibit increased expression of GLUT2 and its mRNA, but not
GLUTI [551. Thus, increased expression of low affinity transport-
ers is responsible for the increased facilitated glucose transport
observed in diabetes. The cellular locus of the increased GLUT2
cannot be assumed to be the BLM, because, as indicated above,
the diabetic small intestine expresses GLUT2 at both the BLM
and BBM [47, 481.
Signals for adaptation of sugar transport
Progress in identifying the primary signal responsible for trans-
port regulation has been hampered by the fact that in most studies
carried out to date, it has not been possible to alter only one
variable at a time. The response to diabetes illustrates the
problems involved. Though reduced insulin levels, or hyperglyce-
mia, are obvious stimuli for the intestinal and renal transport
responses, diabetes is associated with changes in the secretion of
other hormones (such as pancreatic glucagon and growth hor-
mone), and these must also be considered as possible candidates
for adaptation. Intestinal glucose transport may also be affected
by diabetic hyperphagia and the associated changes in luminal
glucose levels.
Insulin receptors have been detected on intestinal epithelial
cells [561. However, exposure of isolated villus enterocytes to
insulin is without effect on BBM and BLM glucose transport [57].
Thus, although administration of insulin to animals inhibits BBM
glucose transport at physiological levels [58, 59], and stimulates
BBM glucose transport at pharmacological levels [601, these
responses are unlikely to be mediated by insulin per sc at the level
of the enterocyte. These observations also make it likely that
reduced insulin secretion alone is not the cause of the up-
regulated sugar transport seen in diabetes [61], and that other
factors contribute to the changes seen in this condition. This
conclusion is strengthened by the observation that, although acute
hyperglycemia induced by intravenous infusion of glucose en-
hances BLM glucose transport within four hours, there is no
correspondence between the rate of up-regulated sugar transport
and plasma concentrations of insulin [621. This, together with the
fact that other sugars were unable to mimic the enhancing effect
of glucose, suggests that plasma glucose concentration, rather
than enhanced insulin secretion, is the critical trigger for the
elevated BLM glucose transport in response to acute hyperglyce-
mia. Comparison of changes in the magnitude of the BBM
electrical potential difference with changes in plasma glucose and
Table 3. Factors and conditions that have been shown to cause rapid
changes in intestinal glucose transport (within 30 minutes), and their
proposed membrane site of action
Stimulus
Effect on glucose
uptake
Membrane site of
action
Luminal glucose + BBM
Bradykinin a BBM/BLM
Hyperglycemia + BBM/BLM
Pancreatic glucagon +a BBM
cAMP + BBM/BLM
Insulin + ?
Serotonin BBM
Prostaglandin E2 — BBM
Abbreviations are: BBM, brush border membrane; BLM, basolateral
membrane; +, increase; —, decrease.
a Isolated enterocytcs were incubated with the agent, suggesting a direct
site of membrane action
insulin concentrations during intravenous infusion of different
sugars implies that neither glucose, nor insulin, per se is respon-
sible for changes in the electrical driving force for SGLTI-
mediated glucose transport [46]. The effects of insulin on renal
glucose transport are poorly understood. To our knowledge, only
one study has examined the effect of this hormone on renal tubule
glucose uptake in non-diabetic animals, and a small but rapidly
induced stimulatory effect was reported [63]. Other groups have
treated diabetic rats with insulin to normalize plasma glucose
concentrations, and shown a reversal of the effects of diabetes on
GLUT2 transporter levels and on glucose transport [53, 55]. This
change is, at least in part, in the basolateral efflux pathway [55]. As
with intestinal transport, it is unclear whether insulin influences
the renal transport process per se, or whether the response is
mediated by glucose directly, or by other associated hormonal
changes.
There is strong evidence that pancreatic glucagon may regulate
intestinal sugar transport. Plasma concentrations of this peptide
arc elevated in both diabetes and starvation, conditions known to
hyperpolarize the BBM. Mucosal binding of glucagon has been
reported, particularly at the upper villus [64]. Glucagon hyperpo-
larizes the BBM within minutes of its administration [65], and
stimulates sugar transport across both BBM and BLM [66, 67].
The effects of glucagon may be due to generation of cAMP, since
incubation of isolated enterocytes with glucagon raises cellular
levels of cAMP [65], which is known to hyperpolarize the BBM
and stimulate sugar movement across it [65]. Bradykinin [68, 69]
and epidermal growth factor [70] also increase sugar transport at
the cellular level, and therefore these peptides may also be
involved in transport modulation (Table 3).
Other agents have been shown to reduce intestinal sugar
transport. Thus, when intact intestine is exposed to higher extra-
cellular levels of VIP [71], somatostatin [72, 73], prostaglandins
[74] and cholecystokinin octapeptide (CCK8) [75], glucose trans-
port is inhibited. However, the methods used in these studies do
not establish whether these agents act directly on enterocytes.
Another hormone that may influence glucose transport is angio-
tensin II. While there are no published studies of its effect on
intestinal glucose transport, angiotensin II has been shown to
stimulate fluid and glucose absorption along the rat straight
proximal tubule (S3), the site of SGLT1 [76]. The mechanism is
unclear, that is, which transporter is affected, and whether it is due
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to an increase in transporter turnover, or number. Paradoxically,
angiotensin II receptor expression is reduced in proximal tubules
of diabetic rats [77]. Rather than through a direct cellular
mechanism, angiotensin II may also increase glucose uptake by
acting in concert with insulin, and via a hemodynamic effect, divert
blood flow to insulin-sensitive tissues, expressing GLUT4 [78].
Both renal [79] and intestinal [80] BBM glucose transport are
enhanced rapidly by experimental procedures that stimulate poly-
amine synthesis. In the case of intestinal transport, the involve-
ment of polyamines in the regulation of cell turnover has been
known for some time. However, the stimulatory effect on entero-
cyte BBM sugar transport, together with the fact that synthesis of
polyamines is increased by luminal nutrients [81, 82], suggest that
variation in the mucosal level of polyamines may explain the
transport responses to changes in dietary intake and composition.
Finally, and perhaps pathophysiologically relevant, the inflamma-
tory cytokine interleukin-1 has been shown to promote Na-
dependent glucose transport across proximal tubular epithelium
by stimulating Na,K-ATPase activity at the BLM [831.
Cell culture systems
Cultured epithelial cell monolayers provide a potentially useful
experimental system for studying the control of sugar transport at
the cellular level, because individual regulatory factors can easily
be tested for possible effects on the transport process. However,
an important reservation is always to know how representative
these isolated cell systems are of transport function across native
tissue in Situ.
The Caco-2 cell line, although derived from a human colonic
cancer, is the most widely used model for investigating the
transport functions of fully differentiated small intestinal epithe-
hum. There is no information regarding SGLT activity in these
cells, but Nat- and phlorizin-dependent sugar transport have
been reported [84]. GLUT proteins are expressed in Caco-2 cells,
but the isoforms present show differences to those found in
differentiated villus enterocytes [10]. However, it should be noted
that culture conditions for Caco-2 monolayers can influence the
characteristics of the expressed Na-dependent sugar transport
[85], which might also apply to expression of GLUT transporters
[86]. Though, as already mentioned, interpretation of sugar
transport data and transporter characteristics from epithelial cell
cultures must be subject to great caution, it is of interest that gene
expression of GLUT5 by Caco-2 cells is influenced by intracellular
cAMP [87]. If this proves to be the case for other GLUT isoforms,
it could have important implications for our understanding of a
derangement in epithelial transport associated with increased
entcrocyte adenyl cyclase activity, for example, in cholera infec-
tion.
For the renal proximal tubule, the LLC-PKI cell line has
proved to be popular, since SGLT1 activity has been demon-
strated in this model of the S3 proximal tubule [88]. Confluency of
the LLC-PKI monolayer is necessary for SGLT1 expression [89]
and activity of the protein is dependent on the cAMP/protein
kinase pathway [90 —92]. Phorbol esters, which cause a loss of tight
junctions in LLC-PKI monolayers, prevent expression of Na-
dependent sugar transport [93]. Better knowledge of the mecha-
nisms underlying this observation is likely to have implications for
our understanding of the regulation of enterocyte expression of
SGLT1. The concentration of glucose to which LLC-PKI cells are
exposed may he an important extracellular factor, since it is
known that the density of phlorizin binding sites is inversely
related to the glucose concentration in the culture medium [94].
Diabetic complications and renal injury
The pathogenesis of diabetic nephropathy remains unclear, and
probably involves several mechanisms that result in damage to a
variety of cell types, including vascular smooth muscle, endothelial
and glomerular epithelial and mesangial cells [95]. Consequently,
it is difficult to speculate on how the adaptive changes in renal
tubular cell glucose transport outlined above could play a role.
Two general mechanisms of hyperglycemia-induced cell injury
have been proposed: (i) high intracellular glucose accumulation
leading to increased sorbitol formation (via aldose reductase),
which causes cell swelling, changes in membrane permeability and
intracellular electrolytes, inhibition of myo-inositol synthesis and
phosphosphoinositide metabolism, and decreased Na,K-
ATPase activity; and (ii) formation of advanced glycation end-
products, increased matrix deposition and cellular proliferation
(hyperplasia and/or hypertrophy, depending on the tissue) [96,
97].
Enterocytes and renal tubule cells do not seem to be primary
targets for diabetic injury, although they may still play a part. In
these polarized cells, enhanced glucose absorption would not be
expected to result in a significant build up of glucose inside cells,
because of the up-regulation of glucose exit at the BLM. How-
ever, it is of interest that in a rare inherited defect of carbohydrate
metabolism, the Fanconi-Bickel syndrome, which is associated
with a proximal tubulopathy, large kidneys and glycogen accumu
lation within proximal tubule cells, hyperfiltration, microalbumin-
uria, and histological appearances similar to early diabetic gb-
merubopathy are found [98]. This suggests, at least in this
condition, a primary role for abnormal glucose handling in the
proximal tubule in the development of a diabetic-like nephropa-
thy.
It is well established that renal sodium absorption is increased
in diabetic patients, and that this is an important factor in the
development of hypertension and progression of renal injury [20].
Several groups, using the lithium clearance technique, have shown
that sodium absorption is enhanced in the proximal nephron, and
they have proposed a link with glucose absorption, and/or angio-
tensin II [99, 100]. Kumar, Gupta and Spitzer, using NMR
spectroscopy to estimate intracellular [Na] in suspensions of rat
renal proximal tubules, found an early and sustained increase of
approximately 50% in diabetic animals, and also in tubules from
control rats incubated in a medium containing a high glucose
concentration (25 mM) [101]. Though renal (and intestinal)
Na,K-ATPase activity is increased rather than decreased in
diabetes [101, 1021, this change is probably secondary to the rise
in intracellular [Na] concentration, which is also a potential
stimulus to cell growth and hypertrophy [103]. However, hyper-
gylcemia, and an increased transmembrane glucose gradient, may
not be sufficient to produce these changes without an increase in
cellular uptake of glucose. Recent evidence from studies of
mesangial cells in culture indicates that increased glucose uptake
depends on the expression of glucose transporters, which in these
cells leads to damaging cytokinc release (PDGF and TGFb) and
increased extracellular matrix production [104]. It has also been
shown recently that proteinuria itself stimulates Nat-dependent
proximal tubular glucose uptake by an unknown luminal action
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[105], thus perhaps reinforcing any adaptive change in glucose and
sodium reabsorption as renal injuly evolves.
A glucose tranporter isoform that we have only briefly men-
tioned up to now is the insulin-regulated GLUT4, found predom-
inantly in skeletal muscle and adipose tissue (Table 1). While
there is some debate about its presence in renal tubule cells (Fig.
2), up-regulation of cell glucose transport in tissues that express
this isoform might be expected to be a homeostatic response to
maintain cell glucose levels in the absence of insulin. However, in
skeletal muscle, hyperglycemia decreases GLUT4 expression (and
plasma membrane location), but increases GLUTI activity [1061;
this may even exacerbate hyperglycemia, yet prevent muscle cell
injury. Decreased vascular expression of this transporter in the
glomerulus has been postulated to be a factor in diabetic hyper-
filtration [107]: by reducing intracellular ATP generation, im-
paired glucose uptake in vascular smooth muscle cells should
increase cell membrane KATE potassium channel opening and
cause vasorelaxation. A related speculation, relevant to renal
sodium handling, is that if GLUT4 expression in the renal tubule
thick ascending limb is critical to cell glucose uptake, then as in
the glomerular microcirculation, a decrease in GLUT4 activity
(secondary to insulinopenia, or insulin resistance) could result in
increased opening of the apical membrane KATP channel thought
to regulate Na/2Cl/K cotransport [108], and thus stimulate
net sodium reabsorption.
While there is no single cell type, nor unifying cell mechanism,
that accounts for diabetic nephropathy, our improved understand-
ing of the cellular transport of glucose, and its regulation and
relationship to various cytokines, and vasoactive factors, is likely
to provide ways in which we can manipulate glucose handling and
assess the benefits. For example, this can be done by breaking the
cycle of hyperglycemic up-regulation of transport through selec-
tive inhibition of intestinal and renal SGLT, or by selective over-
or under-expression of each glucose transporter in transgenic
animal models, which has already begun.
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Note added in proof
The membrane topology of SGLT1 is now thought to consist of 14
rather than 12 membrane spanning domains. (TURK E, KERNER CJ,
LOSTAO MP, WRIGHT EM: Membrane topology of the human Na/
glucose cotransporter SGLT1. J Biol Chem 271:1925—1934, 1996)
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